Pharm/Biotech
Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 

 

 

Title:  Pharmaceutical composition for muscular anabolism

United States Patent:  6,521,591

Issued:  February 18, 2003

Inventors:  Smeets; Rudolf Leonardus Lodewijk (Venlo, NL); Hageman; Robert Johan Joseph (Waddinxveen, NL)

Assignee:  N.V. Nutricia (Zoetermeer, NL)

Appl. No.:  500802

Filed:  February 10, 2000

Abstract

A pharmaceutical composition suitable for enhancing muscular anabolism contains, per daily dose, at least 5 mg of anabolic initiators comprising anabolic growth factors, at least 0.12 g of protein equivalents of anabolic substrates and at least 3 g of anabolic facilitators comprising at least 1 g of creatine or its functional analog. The anabolic initiators may be derived from a non-denatured animal protein, non-denatured being defined as having an F0 of less than 3.0.

DESCRIPTION OF THE INVENTION

It has now been found that the simultaneously or sequential administration of

1-component that triggers anabolism (initiators),

2-components that provide building blocks (substrates) for biosynthesis of muscle tissue, and

3-components that facilitate biosynthetic processes (facilitators) increases, for a certain period of time, lean body mass and/or can prevent catabolism in periods of rest.

Sequential use means that the different components can be administered separately during the day, but they must be consumed during the same day. In this way, for example a product with one or more facilitators is consumed first, followed by consumption, e.g. 2 hours after consumption of the first product, of an effective amount of substrate and initiator in the same product. However, preferably all three types of components are consumed simultaneously in one product.

The invention pertains to pharmaceutical and/or nutritional compositions suitable for enhancing muscular anabolism, i.e. production of muscle tissue or reduction of loss of muscle tissue. The compositions according to the invention comprise an initiator for muscular tissue production, a facilitator for biosynthesis, and a substrate. They furthermore comprise a facilitator, including creatine or a functional equivalent, and optionally further components facilitating tissue production, and also a substrate comprising e.g. carbohydrates, amino acids etc.

The products can have a powdered structure, packed in sachets or cans or similar reservoirs. Other dry forms that are equally suitable are cereals and bars. The product can also have the form of a drink, e.g., based on a dairy drink (mil, whey) or fruit juice (orange, apple, grape). For liquid products it is advantageous to let it have a pH below 4.2 in order to stabilize some of the active components. The product can also have the form of a paste or spread or sauce.

Initiators

The initiators (also referred to as triggering substances or triggers) to be used in the compositions of the invention are components that start up the anabolic processes. Examples are anabolic growth factors like Insulin-Like Growth Factor (IGF-1). These must be present as part of an extract of a protein-rich food ingredient, in particular in an extract from a proteinaceous material of animal origin, like mil, blood or egg. Undenatured whey and especially undenatured colostrum in particular bovine colostrum comprises a variety of anabolic trigger substances. The high effectivity of whey and colostrum that was found may also be explained by the presence of components that increase the bioavailability of the initiator components. In case of anabolic growth factors, such components are binding proteins.

Specific extracts of animal origin may be used as a source of triggers for anabolism, providing that the extraction procedures do not affect the trigger components. The F0 value, defined in the Manual of Common Methods, defines decimal reductions of germs as a result of heat treatment of food products. Thus an F0 value of 3.0 defines a thousand-fold reduction of germs and is achieved by treatment at 121oC. with a Z value of 10. A heat treatment above F0 =3.0 normally destroys most of these trigger components. Thus the extracts should not have been subjected to a heat treatment with an F0 of 3.0 or higher, and preferably any heat treatment should have an F0 of less than 2.4. Most preferably, a heat treatment, if any, should not have a F0 of more than 0.2.

Suitable methods for obtaining such products avoiding substantial heat treatment are described in the art and include filtration and centrifugal techniques. The amount of extract can be as low as 5 mg per daily dose, if a high degree of purification of the triggering substances from the proteinaceous material is obtained. However, when bovine colostrum is used as sole source for triggering substances, at least 5 g of the product, that is obtained by using the method disclosed in WO 97/16977, should be included in a daily dose according to the invention.

The inclusion of insulinotrohic components like digestible carbohydrates and arginine and lysine can further enhance the triggering activity of extracts of animal proteins. Arginine and lysine should be included in amounts of more than 1.0 g and preferably more than 1.5 g per daily dose. Carbohydrates are preferably glucose polymers like maltodextrines and should be present in an amount of more than 4 g and preferably more than 8 g.

Substrates

In order to allow an adequate rate of biosynthesis of muscle tissue, the presence of sufficient amounts of substrate in the form of a variety of amino acids is required. It appears that requirements for protein in athletes are higher than in non-athletes. Daily requirements in strength athletes are above 120 g protein and in endurance athletes above 100 g protein. Though it appeared that some amino acids become rate-limiting earlier in biosynthesis of muscle tissue than other ones, a mixture of all amino acids, including the essential amino acids is preferably provided according to the invention. These amino acids should be provided as protein or hydrolysate thereof; it is especially preferred to use intact protein for taste reasons and because the amino acids will then be released more slowly. The latter ensures a constant but sufficient provision of the substrate amino acids to the tissues and where the amino acids are insulinotrophic, a longer increase of plasma insulin levels.

In order to provide sufficient amounts of amino acids, typically more than 5 g protein and especially more than 10 or even more than 20 g protein in included in the formulations. Suitable proteins are all proteins that comprise high amounts of essential amino acids, especially leucine, lysine and methionine, such as casein, soy, pea, potato, egg and whey proteins. However, when undenatured proteins of animal origin like colostrum or whey from mammal mil, blood or eggs are used, these ingredients also comprise triggering components for anabolism.

Proteins and amino acids can be expressed as protein equivalents (PE). One PE can be calculated by multiplying the Kjeldahl nitrogen content of the substrate by the factor 6.25.

In order to increase the amount of the amino acids that are most critical to muscle building, methionine, lysine and leucine, additional amounts of these amino acids can be included. This can be done by including peptides, or amino acid complexes or free amino acids in the formula. Preferably free amino acids are used, especially those in the L-form. The amounts of methionine that are included per daily serving should exceed 0.2 g (9.4% N: 0.12 g PE) and preferably exceed 0.5 g; the preferred range is 1-6 g Met. Preferably the amount of methionine is more than 2.8 g per 100 g protein equivalents and in particular in the range 3.0-5.0. The amount of lysine per daily serving should be more than 1.0 g (19.6% N: 1.3 g PE) and preferably more than 2.0 g, e.g. 2.5-15.0 g. Calculated per 100 g protein equivalents, the amount of lysine should be more than 8.3 g, and in particular in the range 8.5-11. The amount of leucine per daily serving should be more than 2.0 g (10.4% N: 1.3 g PE) and preferably more than 3.0 g, e.g. 3.5-20 g.

Sleeping disorders are often experienced, especially in those persons that consume large amounts of branched chain amino acids (BCAA valine, isoleucine, leucine). This is especially undesirable when one wants to maintain anabolism during a longer period of time. For this reason it is important that the ratio of L-leucine/BCAA is relatively high. This ratio should be higher than 0.46 and in particular be in the range 0.5-0.3.

In addition the amount of L-tryptophan should be relatively high. The ratio Trp/BCAA should be higher than 0.055, preferably in the range of 0.06-0.2 and in particular be in the range of 0.07-0.13. Also persons that suffer from disease frequently appear to experience problems with maintaining nitrogen balance. By consuming the above-mentioned types and amounts of substrates their capacity to synthesize muscle tissue is maximally supported.

Facilitator

According to the invention, lean body tissue can only be synthesized when sufficient energy is available and sufficient amounts of cofactors are available as facilitator of the anabolic biochemical processes. Intracellular energy should be available in the form of adenosine tri-phosphate (ATP). Creatine phosphate (CP) is able to provide "energized phosphate" to ADP, which restores ATP levels once they have been used for labor or biochemical processes. It is therefore especially advantageous to include in the formulation a source of both energy, in the form of digestible carbohydrates, and creatine. Instead of creatine, Krebs cycle intermediates such as citrate and Krebs cycle precursors, such as pyruvate, glutamate, glutamine, can be used.

The amount of digestible carbohydrates should be above 4 g per daily dose and preferably more than 10 g per day. That of creatine should be above 1.0 g per daily dose and preferably more than 2.0 g, for example 8 g. Suitable carbohydrates are maltodextrines, e.g. the one having DE=19, lactose, sucrose or mixtures thereof. Creatine can be the salt creatine, creatine phosphate, or functional and stable equivalents thereof.

Because of the high amounts of protein that are digested, consumption of extra amounts of minerals and vitamins in the diet is desirable. Especially vitamin B6 should be fortified to ensure to allow a consumption of at least 1.8 mg vit. B6 per 100 g protein that is consumed. The high volume of protein normally consumed by body building ensures a load of methionine that should be handled appropriately in order to have only moderate increases in plasma levels of homocysteine. It is therefore recommended to include folic acid, vitamin B12, vitamin B6, zine and magnesium in the formula, because deficiencies of one or more of these compounds frequently occur, while they are mandatory for homeostasis of homocysteine loads. The levels should be at least 1 mg vitamin B6, 200 .mu.g folic acid, 1 .mu.g cyanocobalamine, 40 mg magnesium and 5 mg zinc or the functional equivalents of these components per daily serving. The prior art discloses which forms of these components can be advantageously used for nutritional purposes. Vitamin B6 can e.g. have the form of principles or pyridoxal; folic acid can be in the monoglutamate form; zinc can be administered as salt, e.g. as zine carbonate; magnesium can have the form of an inorganic salt like magnesium carbonate.

A further improvement of the product can be obtained by including in the product one of the metabolites of leucine, especially beta-hydroxy-beta-methylbutyrate (HMB). The latter compound can be included in an amount of 1-20 g per daily serving, in particular in the range 2-5 per day. The component can be included as pure substance or as inorganic salt such as the calcium salt, or any other functional equivalent. Other components like yeast, carnitine, pyruvate, dihydroxyactone, glutamine, ubiquinone (especially CoQ10) and other vitamins and minerals can be included as well. It is especially preferred to include melatonin, which supports the anabolic function of the composition.

Table 1 shows the scope of the products according to the invention.

 

                             TABLE 1
              Components according to the invention
    Initiators             Substrates    Facilitators
    Undenatured extracts from Proteins      Creatine and/or Krebs cycle
    proteinacous material of and/or        intermediates or precursors
    animal origin +        L-leucine     thereof +
    optionally extra:      L-methionine  optionally
    insulinotrophic components L-lysine      digestible carbohydrates +
    like:                                optionally extra:
    digestible carbohydrates               vitamin B6, folic acid,
    L-Arginine                           vitamin B12
    L-Lysine                             magnesium, zinc
    and/or                               melatonin
    HMB

Claim 1 of 13 Claims

We claim:

1. A pharmaceutical composition containing, per daily dose:

at least 5 mg of anabolic initiators comprising anabolic growth factors,

at least 0.12 g of protein equivalents as anabolic substrates, the protein equivalents comprising a weight ratio of leucine to branched-chain amino acids between 0.5 and 3.0, and

at least 3 g of anabolic facilitators comprising at least 1 g of creatine or its functional equivalent.

 


____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.

 

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]